|
ZNF585A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.91126999999902E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.30529999999396E-05 |
| Normal-vs-Stage2 |
1.306430E-02 |
| Normal-vs-Stage3 |
1.023510E-02 |
| Normal-vs-Stage4 |
2.402000E-02 |
| Stage1-vs-Stage2 |
9.323800E-01 |
| Stage1-vs-Stage3 |
8.732000E-01 |
| Stage1-vs-Stage4 |
8.461600E-01 |
| Stage2-vs-Stage3 |
8.538000E-01 |
| Stage2-vs-Stage4 |
8.969400E-01 |
| Stage3-vs-Stage4 |
7.977400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.1646999999958E-05 |
| Normal-vs-AfricanAmerican |
2.182700E-03 |
| Normal-vs-Asian |
6.034100E-04 |
| Caucasian-vs-AfricanAmerican |
7.192800E-01 |
| Caucasian-vs-Asian |
5.596100E-02 |
| AfricanAmerican-vs-Asian |
4.987600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.75169999961211E-07 |
| Normal-vs-Female |
1.122760E-01 |
| Male-vs-Female |
1.862020E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.444400E-03 |
| Normal-vs-Extreme_Weight |
8.90489999516575E-08 |
| Normal-vs-Obese |
7.292100E-02 |
| Normal-vs-Extreme_Obese |
1.287820E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.284210E-01 |
| Normal_Weight-vs-Obese |
2.858000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.709200E-01 |
| Extreme_Weight-vs-Obese |
3.220100E-03 |
| Extreme_Weight-vs-Extreme_Obese |
9.022000E-01 |
| Obese-vs-Extreme_Obese |
1.308250E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.174200E-02 |
| Normal-vs-Age(41-60Yrs) |
9.335400E-03 |
| Normal-vs-Age(61-80Yrs) |
1.06950000000605E-06 |
| Normal-vs-Age(81-100Yrs) |
1.38179999997767E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.713200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.202200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.167240E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.441700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.580000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.540230E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.4952000000027E-05 |
| Normal-VS-Type2 PRCC |
2.32850000003726E-06 |
| Normal-VS-KIRP CIMP |
3.890600E-01 |
| Normal-VS-Unclassified PRCC |
6.246200E-02 |
| Type1 PRCC-VS-Type2 PRCC |
9.954200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.922400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.421200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.418000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.502370E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.468600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.79299999975613E-07 |
| Normal-vs-N1 |
1.409210E-01 |
| Normal-vs-N2 |
5.67339999999472E-05 |
| N0-vs-N1 |
1.388810E-01 |
| N0-vs-N2 |
1.573840E-01 |
| N1-vs-N2 |
1.099800E-01 |
|
|
